Cited by 55Hepatocellular Carcinoma Treatment and PrognosisCancer, Hypoxia, and MetabolismAmino Acid Enzymes and Metabolism

Prognostic significance of glutamine synthetase expression in unifocal advanced hepatocellular carcinoma

Osada, Takuya, Nagashima, Ikuo, Tsuno, Nelson H, Kitayama, Joji, Nagawa, Hirokazu·2000·Journal of Hepatology

Abstract

Background/aims Glutamine synthetase (GS) catalyzes the synthesis of glutamine, a major energy source of cells, and is upregulated in a subset of human hepatocellular carcinomas (HCCs). GS expression may be related to tumor recurrence, since GS-expressing tumors have a growth advantage in that they are independent of the extracellular glutamine supply. However, there are no studies concerning the prognostic value of GS expression in patients with HCC.Methods Seventy-three patients with a single advanced HCC nodule who underwent curative hepatectomy were included in the study. GS expression in the HCC nodules was analyzed immunohistochemically and was compared with clinicopathologic features and the behavior of the tumors. Survival curves were assessed according to the Kaplan-Meier product-limit method and multivariate analysis based on the Cox regression model was performed.Results GS expression was strong in 26 cases (35.6%, high-GS group) and weak or absent in 47 cases (64.4%, low-GS group). Univariate analysis showed that the high-GS group had a significantly shorter disease-free survival time than the low-GS group (p=0.042). Multivariate analysis revealed that GS expression (p=0.021), as well as Child's classification (p=0.005) and portal invasion (p=0.039), was a significant and independent prognostic parameter that affected tumor recurrence.Conclusion The results of this study indicate that GS expression may enhance the metastatic potential in HCC, and GS immunostaining may be helpful in identifying HCC patients at high risk for disease recurrence.

Integrity signals

Registry

Crossref · 10.1016/s0168-8278(00)80365-7

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Glutamine synthetase is overexpressed in some cancers.

    “Glutamine synthetase (GS) has been found to be overexpressed in some cancers (Osada et al., 2000);”

    From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Osada et al., 2000

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Osada, T., Nagashima, I., Tsuno, N. H., Kitayama, J., & Nagawa, H.
Affiliations
  • The University of Tokyo (JP)
  • Teikyo University (JP)
Corresponding author
Osada, Takuya
Venue
Journal of Hepatology
Publisher
Elsevier BV
Published
2000-08
Volume
33
Issue
2
Pages
247-253
ISSN
0168-8278 (ISSN-L)
OpenAlex
W2110379988
Cited by
55
References
38
Citations by year
2026: 2 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 2 · 2021: 3 · 2020: 1 · 2019: 4 · 2018: 1 · 2017: 3 · 2016: 7 · 2015: 3 · 2014: 1 · 2013: 3
FWCI
0.97
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Hepatology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
Keywords
glutamine synthetase, hepatocellular carcinoma, prognostic factors, tumor recurrence, disease-free survival, hepatectomy, Child-Pugh score, portal vein invasion, glutamine metabolism, metastatic potential
MeSH terms
Adult, Aged, Aged, 80 and over, Female, Glutamate-Ammonia Ligase, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Male, Middle Aged, Prognosis, Biomarkers, Tumor, Survival Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review